On June 29, Sinopharm Group rose 3.04% in regular trading, trading at HK$16.26/share, with turnover of HK$38.70 million.

On the news front, the stock is experiencing a technical recovery following its ex-dividend date on June 23. The company recently signed a strategic cooperation agreement with Sunshine Lake Pharma, under which both parties will deeply integrate distribution resources and innovative product portfolios to accelerate market coverage of innovative drugs. Additionally, the company's annual general meeting previously approved a buyback authorization of up to 10% of issued H shares, providing price support. The final dividend of RMB 0.69 per share will be paid on August 18, with the record date set for June 30.

Within the Health Care Distributors sector, individual stocks showed mixed performance: 160 Health up 6.65%, SH Pharma up 2.92%, Baiyunshan PH up 2.89%, YSB up 11.3%, Guanze Medical down 3.51%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)